Erste Asset Management GmbH bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 113,448 shares of the financial services provider’s stock, valued at approximately $9,357,000.
A number of other large investors also recently made changes to their positions in MET. Vinva Investment Management Ltd grew its holdings in MetLife by 10.8% in the 3rd quarter. Vinva Investment Management Ltd now owns 27,582 shares of the financial services provider’s stock valued at $2,275,000 after buying an additional 2,696 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in MetLife by 20.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 763,521 shares of the financial services provider’s stock worth $62,975,000 after acquiring an additional 130,393 shares during the period. First Commonwealth Financial Corp PA raised its stake in MetLife by 0.8% in the 3rd quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider’s stock worth $1,375,000 after purchasing an additional 133 shares in the last quarter. Finally, CreativeOne Wealth LLC boosted its holdings in MetLife by 27.6% in the 3rd quarter. CreativeOne Wealth LLC now owns 8,959 shares of the financial services provider’s stock valued at $739,000 after purchasing an additional 1,938 shares during the period. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Down 0.0 %
Shares of NYSE:MET opened at $88.23 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $63.02 and a 52-week high of $89.05. The company has a market capitalization of $61.09 billion, a PE ratio of 17.79, a price-to-earnings-growth ratio of 0.81 and a beta of 1.05. The company has a fifty day moving average of $83.34 and a 200-day moving average of $76.61.
MetLife Announces Dividend
Analyst Ratings Changes
MET has been the topic of several recent research reports. Morgan Stanley lowered their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Piper Sandler lifted their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Jefferies Financial Group increased their target price on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. TD Cowen upped their price objective on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Finally, Barclays decreased their target price on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Fourteen analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $88.62.
Get Our Latest Stock Report on MET
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Health Care Stocks Explained: Why You Might Want to Invest
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Why Are Stock Sectors Important to Successful Investing?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.